Literature DB >> 17311370

Use of simple docking methods to screen a virtual library for heteroactivators of cytochrome P450 2C9.

Charles W Locuson1, Peter M Gannett, Robyn Ayscue, Timothy S Tracy.   

Abstract

Several laboratories have demonstrated that activation of drug metabolism by P450s may occur via a mechanism that resembles allosterism from an enzyme kinetic standpoint. Because the effector drug binding site may be located in the same P450 binding pocket where the drug substrate is located, the ability to find and characterize novel effectors (aka heteroactivators) will prove to be important in probing the mechanism of activation. We have used analogues of the prototypical CYP2C9 heteroactivator dapsone to validate a simple docking method that can be used to predict heteroactivators based on ligand binding location in a P450 crystal structure. As proof of concept for the described docking method, a protocol was developed to discover potential heteroactivators from a virtual chemical library through efficient sorting of >40,000 compounds. One of the top-scoring compounds identified was verified to be a CYP2C9 heteroactivator in vitro, and it possessed activity similar to dapsone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17311370      PMCID: PMC2519618          DOI: 10.1021/jm060706p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

1.  CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin.

Authors:  Tina M Bland; Robert L Haining; Timothy S Tracy; Patrick S Callery
Journal:  Biochem Pharmacol       Date:  2005-10-01       Impact factor: 5.858

Review 2.  Predicting in vivo drug interactions from in vitro drug discovery data.

Authors:  Larry C Wienkers; Timothy G Heath
Journal:  Nat Rev Drug Discov       Date:  2005-10       Impact factor: 84.694

3.  Binding mode prediction of cytochrome p450 and thymidine kinase protein-ligand complexes by consideration of water and rescoring in automated docking.

Authors:  Chris de Graaf; Pavel Pospisil; Wouter Pos; Gerd Folkers; Nico P E Vermeulen
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

Review 4.  Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions.

Authors:  William M Atkins
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

Review 5.  Inhibition constants, inhibitor concentrations and the prediction of inhibitory drug drug interactions: pitfalls, progress and promise.

Authors:  K A Bachmann
Journal:  Curr Drug Metab       Date:  2006-01       Impact factor: 3.731

6.  Heteroactivator effects on the coupling and spin state equilibrium of CYP2C9.

Authors:  Charles W Locuson; Peter M Gannett; Timothy S Tracy
Journal:  Arch Biochem Biophys       Date:  2006-03-02       Impact factor: 4.013

7.  Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences.

Authors:  O Gotoh
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

8.  Crystallographic study on the dioxygen complex of wild-type and mutant cytochrome P450cam. Implications for the dioxygen activation mechanism.

Authors:  Shingo Nagano; Thomas L Poulos
Journal:  J Biol Chem       Date:  2005-06-30       Impact factor: 5.157

9.  Structural basis for ligand promiscuity in cytochrome P450 3A4.

Authors:  Marika Ekroos; Tove Sjögren
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-05       Impact factor: 11.205

10.  Lansoprazole enantiomer activates human liver microsomal CYP2C9 catalytic activity in a stereospecific and substrate-specific manner.

Authors:  Kwang-Hyeon Liu; Min-Jung Kim; Woo Moon Jung; Wonku Kang; In-June Cha; Jae-Gook Shin
Journal:  Drug Metab Dispos       Date:  2004-11-10       Impact factor: 3.922

View more
  6 in total

1.  Multiple ligand docking by Glide: implications for virtual second-site screening.

Authors:  Márton Vass; Ákos Tarcsay; György M Keserű
Journal:  J Comput Aided Mol Des       Date:  2012-05-26       Impact factor: 3.686

Review 2.  Formation of P450 · P450 complexes and their effect on P450 function.

Authors:  James R Reed; Wayne L Backes
Journal:  Pharmacol Ther       Date:  2011-11-29       Impact factor: 12.310

Review 3.  Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering.

Authors:  Irina A Pikuleva
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-11       Impact factor: 4.481

4.  Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain.

Authors:  Natalia Mast; Mark Andrew White; Ingemar Bjorkhem; Eric F Johnson; C David Stout; Irina A Pikuleva
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-09       Impact factor: 11.205

5.  Effective virtual screening protocol for CYP2C9 ligands using a screening site constructed from flurbiprofen and S-warfarin pockets.

Authors:  Tímea Polgár; Dóra K Menyhárd; György M Keseru
Journal:  J Comput Aided Mol Des       Date:  2007-10-25       Impact factor: 3.686

6.  Inhibition of CYP2B4 by 2-ethynylnaphthalene: evidence for the co-binding of substrate and inhibitor within the active site.

Authors:  Dongmei Cheng; Danni Harris; James R Reed; Wayne L Backes
Journal:  Arch Biochem Biophys       Date:  2007-10-04       Impact factor: 4.013

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.